00:01
Welcome!
With this talk, we're going
to cover Wilson's disease.
00:05
And like all the eponymous diseases
named after a patient or a doctor,
and unless you remember
what it's about, it
and doesn't help you
in terms of the name.
00:13
But after this talk, you will hopefully
remember that Wilson's disease
is an autosomal
recessive disorder.
00:19
It's characterized by copper
accumulation in a variety of organs,
and mostly liver and
brain and cornea.
00:25
And since clearly,
this is a talk that's in the GI
pathophysiology series of talks.
00:31
We're going to emphasize
what goes on in the liver.
00:33
But we'll look at some of
those other organs as well.
00:37
The epidemiology of this,
it's a relatively rare entity,
but one you should be aware of
about one per
30,000 live births.
00:46
Because of the
copper accumulation,
patients who are going
to be symptomatic,
tend to present
relatively early in life.
00:53
And so it can be in the pediatric
population or in young adulthood.
00:59
The pathophysiology, the
problem with this disease,
is we have lost a copper
transporting protein.
01:07
The gene itself is
indicated there ATP7B,
it's an ATPase, it's
on chromosome 13.
01:13
Do not memorize that.
01:15
Just know that the necessary or
the important protein in this
is a copper exporter,
it will allow the hepatocytes
to get rid of excess copper.
01:26
So what's the normal pathway of
copper absorption within the GI tract?
So copper like iron is absorbed
in the duodenum and ileum.
01:34
And here we have
absorbed and going
through the portal
circulation to the liver,
where it is taken up by
specific ATPase is taken up
by the hepatocytes.
01:45
Hepatocyes will use it
for a variety of things.
01:47
It's important as unnecessary
cofactor in electron transport,
and superoxide
dismutase activity
and in matrix crosslinking.
01:56
It's also important that
we get rid of the excess.
02:01
So you don't want a
lot of the city around
because it will generate
oxygen free radicals
which will cause damage
to the hepatocytes.
02:11
So any excess copper is
excreted through the bile
and then ends up going
away in the stool.
02:19
So if we cannot excrete
the excess copper,
due to the mutations
in the transporter,
we'll get accumulation
of the copper
and the hepatocytes
will undergo apoptosis.
02:34
We can see similar excess
accumulations of copper
and a variety of other tissues,
which will lead to injury.
02:40
And the more common areas
where we will see pathology or
in the brain and in the eye.
02:46
And in the kidney.
02:48
The clinical presentation
for Wilson's disease.
02:51
So the liver disease,
which is going to be probably
our earliest manifestation
that's going to be anything
that you can expect
going wrong with the liver
leading to hepatomegaly.
03:03
An accumulation of the copper,
but eventually with
ongoing apoptosis,
this is going to
progress to cirrhosis.
03:11
And then everything we've talked
about when we talk about cirrhosis.
03:14
So go back to that
other talk in the series
when we talk about cirrhosis.
03:19
And you'll remember everything
that's on this list.
03:22
The neurologic symptoms occur
because the neurons
in the basal ganglia
and the associated parenchymal
cells, astrocytes etc.
03:32
In the basal ganglia, the
cerebellum and the cerebrum
accumulate excess copper,
which leads to defects in the
normal activity of these neurons.
03:42
In the basal ganglia,
we will have defects
that are associated with tremor,
or with movement disorder.
03:49
And that's what the basal
ganglia are responsible for.
03:52
In the cerebellum while
we get dysarthria.
03:54
So the - not being able to
speak appropriately, dysarthria.
03:58
You may also get
dysphasia in coordination
and inability to walk or ataxia.
04:04
In the cerebrum, you may actually
have psychosis and dementia.
04:08
There will be hemolytic disease.
04:11
It's a Coombs-negative,
so there's no antibody
associated hemolytic anemia,
and this will exacerbate
the liver jaundice
because we're getting breakdown
or hemolysis of red cells.
04:22
This is happening
because of excess levels
of circulating amounts of copper
that copper is accumulated
within the erythrocytes
probably leading to instability
of the plasma
membrane of the cells,
but also leading
to increased rates
of oxidation of hemoglobin,
and also with inhibition
of the pentose monophosphate
shunt, for example.
04:47
So that the erythrocytes don't
have their normal capacity
to maintain their architecture.
04:53
That Hemolytic Anemia
is commonly seen
with acute liver failure
in Wilson's disease.
04:59
A characteristic finding
on clinical examination
is the Kayser-Fleischer ring.
05:04
This is a copper deposition
in decimates membrane,
in the cornea,
and it will be present
in almost all patients
who have neurologic or
psychiatric presentations.
05:14
And if you just have
hepatic disease,
roughly 50% of patients
will have this,
but it's an easy marker to see.
05:21
How are we going to
make the diagnosis?
So it's a physical examination
in a juvenile who is presenting
with signs of liver failure
with or without the central
nervous system manifestations.
05:32
We will do a slit
lamp examination
looking for the
Kayser-Fleischer ring.
05:37
And then we will do
additional laboratory workup.
05:41
So with hepatocyte injury
due to the excessive
accumulation of the copper,
we will see elevated
transaminitis.
05:49
Characteristically the AST to
ALT ratio is greater than 2.
05:53
Personally, I can
never remember that.
05:55
And it's nonspecific.
05:57
So I would just say there's
elevated transaminitis.
06:00
There will be decreased
serum ceruloplasmin.
06:02
So ceruloplasmin is the
normal circulating protein
that binds up copper,
and also can carry it
out of the bloodstream.
06:11
With elevated levels of copper,
more, the ceruloplasmin
is binding,
and that level goes down.
06:17
Now it's also
synthesized by the liver
and as we get
progressive liver damage
will make less of
the protein as well.
06:23
But that decrease ceruloplasmin
is actually a pretty good marker
for too much circulating copper.
06:29
We can also look for copper
being excreted in the kidneys,
so we can actually do a 24 hour
urine sampling and measure that.
06:37
And a complete blood count.
06:39
And mainly we're looking for
signs of hemolytic anemia.
06:44
Imaging, we can do an ultrasound
and look for cirrhosis,
but that's really
kind of too far along.
06:50
We want to actually
prevent cirrhosis.
06:53
So the gold standard test
once you've documented
that you have low ceruloplasmin.
06:57
And you've had elevated
levels of circulating copper,
particularly in a 24
hour urine sampling.
07:02
We're going to do
a liver biopsy.
07:04
And we're going to
see increased copper
detected by quantitative assays.
07:08
We can then also do the specific
molecular genetic analysis
looking for mutations in
the transporter ATPase.
07:15
How are we going to
manage these patients?
Let's cut the copper up.
07:19
So no more eating pennies.
07:21
No, that's not
the way you do it.
07:22
But there are a lot of foods that
are relatively rich in copper,
so you reduce that.
07:28
Any excess copper that
is in the circulation,
you can administer
drugs that kill it
and allow you to
urinate it away.
07:36
If it's poorly tolerated to
take penicillimine or others,
you can do oral zinc,
which in many ways will help
with the excretion of the copper.
07:44
And in for very severe cases,
because we're lacking
the necessary enzyme.
07:50
We'll give them a brand new
liver to start over with.
07:53
And that may be all that you can do
once you have in stage cirrhosis.
07:58
With that,
we will talk about prognosis.
08:01
So five year median survival
after the parents have
neurologic symptoms.
08:05
That's not great.
08:06
But if we're able to manage and
reduce the levels of copper overall,
they can do quite well.
08:14
95% of patients who
develop acute liver failure
will die within days without
liver transplantation.
08:23
As I was intimating
in the previous slide,
survival with appropriate
treatment is excellent.
08:27
Even in the presence
of liver damage,
we just have to minimize
further accumulation
of more injury to the liver.
08:35
We'll conclude here
with a little bit about
copper metabolism
and Wilson's disease.